Highlights
- •Repeat SARS-CoV-2 testing after admission is key in suspicious cases
- •Whole genome sequencing can assist with outbreak investigations
- •Increased patient contact time is a risk factor for nosocomial SARS-CoV-2 infection
- •Performing aerosol-generating procedures increases nosocomial SARS-CoV-2 risk
Abstract
Background
Methods
Results
Discussion
Conclusions
Key Words
Background
CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2021 Jan 13]. Available at: https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov-2.html. Accessed October 6, 2021.
Shortage of personal protective equipment endangering health workers worldwide [Internet]. [cited 2021 Jan 4]. Available at:https://www.who.int/news/item/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide. Accessed October 6, 2021.
Nguyen LH, Drew DA, Graham MS, et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health [Internet]. 2020 Jul 31 [cited 2020 Aug 3];0(0). Available at: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(20)30164-X/abstract. Accessed October 6, 2021.
- Oda G
- Sharma A
- Lucero-Obusan C
- Schirmer P
- Sohoni P
- Holodniy M
Nguyen LH, Drew DA, Graham MS, et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health [Internet]. 2020 Jul 31 [cited 2020 Aug 3];0(0). Available at: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(20)30164-X/abstract. Accessed October 6, 2021.
- Kambhampati AK
- Taylor J
- Carter RJ
- Lehnertz N
- et al.
CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2020 Nov 27]. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html. Accessed October 6, 2021.
- Oda G
- Sharma A
- Lucero-Obusan C
- Schirmer P
- Sohoni P
- Holodniy M
- Kambhampati AK
- O’Halloran AC
- Whitaker M
- et al.
COVID-19–associated hospitalizations among health care personnel — COVID-NET, 13 States, March 1–May 31, 2020.
Methods
Index patient
Outbreak investigation and study design
Sequencing methods
Results
Outbreak investigation results

Whole Genome Sequencing
Region | SNP | % of US Cases |
---|---|---|
non-coding region | C241T | 87.3% |
ORF1a: synonymous | C3037T | 87.4% |
ORF1b: P314L | C14408T | 87.3% |
ORF1b: synonymous | C15660T | 0.016% |
ORF1b: A1643V | C18395T | 0.258% |
ORF1b: synonymous | A20268G | 10.2% |
ORF1b: A2431V | C20759T | 0.44% |
S protein: D614G | A23403G | 87.5% |
S protein: synonymous | T24076C | 3.02% |
N protein: S194L | C28854T | 10.2% |
N protein: M210I | G28903T | 0.366% |
non-coding region | G29778T | 0.005% |
Demographic and work characteristics
Cases (N = 7) N (%) | Controls (N = 93) N (%) | Odds Ratio | 95% CI | |
---|---|---|---|---|
Demographics | ||||
Age - mean years (SD); mean difference | 37.000 (6.733) | 36.925 (9.962) | 0.08 | (-7.00 –6.00) |
Female | 5 (71.4%) | 57 (61.3%) | 1.50 | (0.23 –16.59) |
Immunocompromising condition reported | 0 (0.0%) | 7 (7.5%) | 0.00 | (0 –10.58) |
Healthcare Role | ||||
- Nurse | 4 (57.1%) | 25 (26.9%) | 3.57 | (0.56 –26.12) |
- Physician / advanced practice practitioner | 0 (0.0%) | 19 (20.4%) | ||
- Medical or nurse assistant | 1 (14.3%) | 14 (15.1%) | ||
- Respiratory therapist / Speech therapist | 1 (14.3%) | 11 (11.8%) | ||
- Physical or occupational therapist | 1 (14.3%) | 4 (4.3%) | ||
- Manager/social worker/ patient coordinator | 0 (0.0%) | 6 (6.5%) | ||
- Patient technician | 0 (0.0%) | 6 (6.5%) | ||
- Phlebotomist | 0 (0.0%) | 4 (4.3%) | ||
- Food service / environmental service worker | 0 (0.0%) | 4 (4.3%) | ||
Contact with other HCP | ||||
- Yes (contact tested positive) | 1 (14.3%) | 1 (1.1%) | 14.27 | (0.17 –1201.18) |
- Yes (contact tested negative) | 2 (28.6%) | 2 (2.2%) | ||
- Yes (contact with unknown test results) | 0 (0.0%) | 4 (4.3%) | ||
- None | 4 (57.1%) | 86 (92.5%) | ||
PPE practices with index patient | ||||
No breaches in PPE | 7 (100.0%) | 93 (100.0%) | - | - |
Procedure mask | 7 (100.0%) | 93 (100.0%) | - | - |
N95 | ||||
- All the time | 1 (14.3%) | 11 (12.8%) | 0.81 | (0.08 –40.35) |
- More than half the time | 0 (0.0%) | 4 (4.7%) | ||
- Less than half the time | 0 (0.0%) | 10 (11.6%) | ||
- None of the time | 6 (85.7%) | 61 (70.9%) | ||
- No response | 0 | 7 | ||
Gloves | ||||
- All the time | 6 (85.7%) | 70 (77.8%) | 0.51 | (0.01 –4.56) |
- More than half the time | 1 (14.3%) | 5 (5.6%) | ||
- Less than half the time | 0 (0.0%) | 6 (6.7%) | ||
- None of the time | 0 (0.0%) | 9 (10.0%) | ||
- No response | 0 | 3 | ||
Gown | ||||
- All the time | 1 (14.3%) | 12 (14.1%) | 0.89 | (0.09 –44.25) |
- More than half the time | 0 (0.0%) | 4 (4.7%) | ||
- Less than half the time | 0 (0.0%) | 11 (12.9%) | ||
- None of the time | 6 (85.7%) | 58 (68.2%) | ||
- No response | 0 | 8 |
Patient care activities
All survey participants | Restricted to job categories with cases | ||||||
---|---|---|---|---|---|---|---|
Cases (N = 7) N (%) | Controls (N = 93) N (%) | Odds Ratio | 95% CI | Controls (N = 54) N (%) | Odds Ratio | 95% CI | |
Airway procedures | |||||||
Performed AGP | |||||||
Placed on HFNC/CPAP/BiPAP | 5 (71.4%) | 16 (17.2%) | 11.60 | (1.72 –132.08) | 14 (25.9%) | 6.87 | (0.99 –79.76) |
Gave nebulizer treatment | 1 (14.3%) | 6 (6.5%) | 2.39 | (0.05 –25.84) | 6 (11.1%) | 1.33 | (0.02 –14.5) |
Performed endoscopy | 0 (0.0%) | 2 (2.2%) | 0.00 | (0.00 –74.88) | - | - | - |
Performed any AGP | 5 (71.4%) | 19 (20.4%) | 9.44 | (1.42 –106.44) | 17 (31.5%) | 5.28 | (0.77 –60.75) |
Present during AGP | |||||||
Present while HFNC/CPAP/BiPAP was on the patient | 5 (71.4%) | 38 (40.9%) | 3.57 | (0.55 –39.37) | 24 (44.4%) | 3.07 | (0.45 –34.91) |
Present during nebulizer treatment | 4 (57.1%) | 15 (16.1%) | 6.74 | (1.03 –50.85) | 12 (22.2%) | 4.52 | (0.67 –35.28) |
Present during endoscopic procedure | 0 (0.0%) | 7 (7.5%) | 0.00 | (0 –10.58) | 2 (3.7%) | 0.00 | (0 –43.32) |
Present during any AGP | 5 (71.4%) | 43 (46.2%) | 2.88 | (0.44 –31.66) | 27 (50.0%) | 2.46 | (0.36 –28.02) |
Other airway procedures | |||||||
Performed suctioning | 3 (42.9%) | 3 (3.2%) | 20.64 | (2.12 –213.66) | 3 (5.6%) | 11.74 | (1.19 –122.43) |
Present during suctioning | 4 (57.1%) | 14 (15.1%) | 7.30 | (1.11 –55.34) | 8 (14.8%) | 7.29 | (1.03 –59.86) |
Adjust oxygen mask/tubing | 7 (100.0%) | 34 (36.6%) | Inf | (2.3 –Inf) | 29 (53.7%) | Inf | (1.1 –Inf) |
Moving/touching patient | |||||||
Check vital signs | 7 (100.0%) | 37 (39.8%) | Inf | (2.02 –Inf) | 36 (66.7%) | Inf | (0.63 –Inf) |
Perform a history and/or physical exam | 4 (57.1%) | 35 (37.6%) | 2.19 | (0.35 –15.85) | 20 (37.0%) | 2.24 | (0.34 –16.84) |
Administer medications | 5 (71.4%) | 21 (22.6%) | 8.34 | (1.26 –93.58) | 21 (38.9%) | 3.84 | (0.57 –43.82) |
Perform blood draw or IV insertion | 1 (14.3%) | 9 (9.7%) | 1.55 | (0.03 –15.28) | 4 (7.4%) | 2.05 | (0.04 –26.1) |
Bathe the patient | 6 (85.7%) | 29 (31.2%) | 12.91 | (1.47 –616.19) | 29 (53.7%) | 5.06 | (0.56 –246.94) |
Position the patient | 6 (85.7%) | 45 (48.4%) | 6.30 | (0.72 –299.94) | 38 (70.4%) | 2.49 | (0.27 –123.29) |
Assist in patient exercises/walking | 4 (57.1%) | 21 (22.6%) | 4.48 | (0.7 –33.04) | 21 (38.9%) | 2.07 | (0.32 –15.58) |
Cleaning | |||||||
Empty bedpan | 5 (71.4%) | 21 (22.6%) | 8.34 | (1.26 –93.58) | 21 (38.9%) | 3.84 | (0.57 –43.82) |
Change linens | 5 (71.4%) | 29 (31.2%) | 5.41 | (0.83 –60.05) | 28 (51.9%) | 2.29 | (0.34- –26.05) |
Empty the trash | 2 (28.6%) | 8 (8.6%) | 4.15 | (0.34 –31.15) | 5 (9.3%) | 3.79 | (0.29 –32.68) |
Clean the patient's room | 2 (28.6%) | 16 (17.2%) | 1.91 | (0.17 –13.01) | 13 (24.1%) | 1.26 | (0.11 –8.88) |
Amount of time spent with the patient
All survey participants | Restricted to job categories with cases | ||||||
---|---|---|---|---|---|---|---|
Cases (N = 7) N (%) | Controls (N = 93) N (%) | Odds Ratio | 95% CI | Controls (N = 54) N (%) | Odds Ratio | 95% CI | |
Total # of days with patient | 5.01 | (1.39 –18.9) | 5.37 | (1.37 –22.51) | |||
- 1 day | 0 (0.0%) | 56 (60.2%) | 31 (57.4%) | ||||
- 2-3 days | 5 (71.4%) | 22 (23.7%) | 15 (27.8%) | ||||
- 4-5 days | 1 (14.3%) | 10 (10.8%) | 5 (9.3%) | ||||
->6 days | 1 (14.3%) | 5 (5.4%) | 3 (5.6%) | ||||
Total amount of time with patient | 4.56 | (1.22 –17.14) | 3.09 | (0.79 –12.16) | |||
- <30 minutes | 1 (14.3%) | 43 (46.2%) | 18 (33.3%) | ||||
- 30 to 60 minutes | 0 (0.0%) | 25 (26.9%) | 17 (31.5%) | ||||
- 1 to 5 hours | 5 (71.4%) | 15 (16.1%) | 11 (20.4%) | ||||
- 5 to 10 hours | 1 (14.3%) | 7 (7.5%) | 5 (9.3%) | ||||
- > 10 hours | 0 (0.0%) | 3 (3.2%) | 3 (5.6%) | ||||
# of patient contacts per day | 7.78 | (1.95 –34.30) | 3.86 | (0.95 –17.32) | |||
- 1-2 times | 1 (14.3%) | 62 (66.7%) | 26 (48.1%) | ||||
- 3-4 times | 1 (14.3%) | 13 (14.0%) | 10 (18.5%) | ||||
- 5-6 times | 1 (14.3%) | 4 (4.3%) | 4 (7.4%) | ||||
- 7-8 times | 1 (14.3%) | 3 (3.2%) | 3 (5.6%) | ||||
- >8 times | 3 (42.9%) | 11 (11.8%) | 11 (20.4%) | ||||
Longest single contact with patient | 14.35 | (3.14 –77.70) | 17.49 | (3.16 –146.78) | |||
- <15 minutes | 0 (0.0%) | 36 (38.7%) | 17 (31.5%) | ||||
- 15-30 minutes | 1 (14.3%) | 32 (34.4%) | 21 (38.9%) | ||||
- 30-60 minutes | 4 (57.1%) | 22 (23.7%) | 15 (27.8%) | ||||
- >60 minutes | 2 (28.6%) | 3 (3.2%) | 1 (1.9%) | ||||
Time with patient during an aerosol generating procedure | 6.56 | (1.55 –30.18) | 5.83 | (1.30 –29.30) | |||
- Zero | 0 (0.0%) | 27 (29.0%) | 14 (25.9%) | ||||
- <15 minutes | 2 (28.6%) | 28 (30.1%) | 15 (27.8%) | ||||
- 15-30 minutes | 1 (14.3%) | 23 (24.7%) | 15 (27.8%) | ||||
- 30-60 minutes | 2 (28.6%) | 11 (11.8%) | 8 (14.8%) | ||||
- >60 minutes | 2 (28.6%) | 4 (4.3%) | 2 (3.7%) |
Discussion
- Taylor J
- Carter RJ
- Lehnertz N
- et al.
Klompas M, Baker M, Rhee C. What is an aerosol-generating procedure? JAMA Surg. 2020;156:113-114. Available at: https://jamanetwork.com/journals/jamasurgery/fullarticle/2774161. Accessed October 6, 2021.
- Cascella M
- Rajnik M
- Cuomo A
- Dulebohn SC
- Di Napoli R
- Tran K
- Cimon K
- Severn M
- Pessoa-Silva CL
- Conly J
CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2020 Nov 27]. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html. Accessed October 6, 2021.
Conclusions
References
- COVID-19 in medical personnel: observation from Thailand.J Hosp Infect. 2020; 104: 453
- Relative contributions of transmission routes for COVID-19 among healthcare personnel providing patient care.J Occup Environ Hyg. 2020; 17: 408-415
CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2021 Jan 13]. Available at: https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov-2.html. Accessed October 6, 2021.
Shortage of personal protective equipment endangering health workers worldwide [Internet]. [cited 2021 Jan 4]. Available at:https://www.who.int/news/item/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide. Accessed October 6, 2021.
- Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants.Occup Environ Med. 2020; 78: 307-314
Nguyen LH, Drew DA, Graham MS, et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health [Internet]. 2020 Jul 31 [cited 2020 Aug 3];0(0). Available at: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(20)30164-X/abstract. Accessed October 6, 2021.
- COVID-19 infections among healthcare personnel in the united states veterans health Administration, March – August, 2020.J Occup Environ Med. 2021; 63 (Available at:): 291-295https://journals.lww.com/joem/Abstract/9000/COVID_19_Infections_Among_Healthcare_Personnel_in.98009.aspxDate accessed: October 6, 2021
- Transmission risk of SARS-CoV-2 to healthcare workers -observational results of a primary care hospital contact tracing.Swiss Med Wkly. 2020; 150: w20257
- A SARS-CoV-2 cluster in an acute care hospital.Ann Intern Med. 2021; 174: 794-802
- COVID-19–associated hospitalizations among health care personnel — COVID-NET, 13 States, March 1–May 31, 2020.MMWR Morb Mortal Wkly Rep. 2020; 69 (Available at:): 1576-1583https://www.cdc.gov/mmwr/volumes/69/wr/mm6943e3.htmDate accessed: October 6, 2021
- COVID-19 infections among HCWs exposed to a patient with a delayed diagnosis of COVID-19.Infect Control Hosp Epidemiol. 2020; 41: 1075-1076
- Whole-genome sequencing to track severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in nosocomial outbreaks.Clin Infect Dis. 2020; 72: e727-e735
- Serial testing for SARS-CoV-2 and virus whole genome sequencing inform infection risk at two skilled nursing facilities with COVID-19 Outbreaks — Minnesota, April–June 2020.MMWR Morb Mortal Wkly Rep. 2020; 69 (Available at:): 1288-1295https://www.cdc.gov/mmwr/volumes/69/wr/mm6937a3.htmDate accessed: October 6, 2021
CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2020 Nov 27]. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html. Accessed October 6, 2021.
- Characteristics and transmission dynamics of COVID-19 in healthcare workers at a London teaching hospital.J Hosp Infect. 2020; 106: 325-329
- COVID-19–associated hospitalizations among health care personnel — COVID-NET, 13 States, March 1–May 31, 2020.MMWR Morb Mortal Wkly Rep. 2020; 69 (Available at:): 1711https://www.cdc.gov/mmwr/volumes/69/wr/mm6943e3.htmDate accessed: October 6, 2021
- Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support.J Biomed Inform. 2009; 42: 377-381
- The REDCap consortium: building an international community of software platform partners.J Biomed Inform. 2019; 95103208
- Next-generation molecular testing of newborn dried blood spots for cystic fibrosis.J Mol Diagn. 2016; 18: 267-282
- Transplant virus detection using multiplex targeted sequencing.J Appl Lab Med. 2018; 2: 757-769
- Nextstrain: real-time tracking of pathogen evolution.Bioinforma Oxf Engl. 2018; 34: 4121-4123
- Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient — Solano County, California, February 2020.Morb Mortal Wkly Rep. 2020; 69: 472-476
- SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.Lancet Microbe. 2021; 2: e13-e22
- A COVID-19 infection risk model for frontline health care workers.Netw Model Anal Health Inform Bioinforma. 2020; 9: 57
Klompas M, Baker M, Rhee C. What is an aerosol-generating procedure? JAMA Surg. 2020;156:113-114. Available at: https://jamanetwork.com/journals/jamasurgery/fullarticle/2774161. Accessed October 6, 2021.
- Aerosol-generating procedures and infective risk to healthcare workers from SARS-CoV-2: the limits of the evidence.J Hosp Infect. 2020; 105: 717-725
- Features, Evaluation, and Treatment of Coronavirus (COVID-19).StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL)2021 ([cited 2021 Jan 13]. Available at:)http://www.ncbi.nlm.nih.gov/books/NBK554776/Date accessed: October 6, 2021
- Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review.PLoS ONE. 2012; 7 (Available at:): e35797https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338532Date accessed: October 6, 2021
Article Info
Publication History
Footnotes
Funding/support: J.I.R. is supported by NIH Training Grant 5T32AI052073-14 and by a Stanford University Maternal Child Health Research Institute grant. P.S., L.H., and W.X. are supported by funding from Open Medicine Foundation. None of the authors received financial or material support for the research and work in this manuscript.
Conflicts of interest: None of the authors have any relevant conflict of interest or other financial disclosures relevant to the subject matter.
Authors’ contributions: J.I.R. and R.T. equally contributed to this paper with study design, literature review and analysis, drafting and critical revision of the manuscript. R.G., P.K., D.K, S.C, K.B, T.M., A.M., and L.T. assisted with data acquisition, outbreak investigation, survey design, and critical review of the manuscript. B.A.P., P.S., L.S., L.H., and W.X. performed molecular sequencing and tracing, assisted with drafting and critical review of the manuscript. M.H. supervised the project, was involved in study and survey design, analysis, drafting and critical review of the manuscript.